Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)	Neoplasm Metastasis, Neoplasms by Site, Neoplastic Cells, Circulating, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma	Recruiting	Not stated	2025-03-19		NCT06717243

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Icahn School of Medicine at Mount Sinai	256
National and Kapodistrian University of Athens	74
Oncology Center of Biochemical Education And Research	1
Sotiria General Hospital	3

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
3rd Department of Medicine, National and Kapodistrian University of Athens, Sotiria Hospital	Athens	Greece	1
Icahn School of Medicine at Mount Sinai	New York	United States	342